Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (29009)	1/27/2005 9:47:32 AM
From: rrufff	Respond to of 120405

IMX breaking $10 at opening. Good (rare) post from Yahoo Re: How does the FDA news translate to $ by: j6proulx 01/27/05 08:42 am Msg: 16619 of 16626 If I recall correctly from past conference calls and PRs, the device will sell for aroud $200,000 and IMX will also collect monthly service fees of $30-$40,000. IMX generally aims to have a 50% margin on its products. As to your question about prototype or finished product, the product development has been completed. The remaining steps are regulatory (registering the radioactive source and obtaining a traceable calibration). I understand the proposed clinical evaluations would be in support of marketing efforts -- it would be a big plus to have references and real-world data to support the sales effort. All IMHO.